+91 88671 25414 · Mon – Fri, 9:30 am – 6:30 pm IST Report a side effect →

Industries

The rules your product must meet

Each industry has its own rules. Find yours below. We show the main rules you face, and the services that help you meet them.

Industry

Pharmaceuticals

The rules you face

In India, medicines are controlled by CDSCO, the national drug regulator. The main law is the Drugs and Cosmetics Act, 1940, with its Rules.

New medicines and clinical trials follow the New Drugs and Clinical Trials Rules, 2019. Every trial needs approval from an ethics committee: a group that checks the study is safe and fair for the people in it.

To sell abroad, you need approval in each market. In the US, that is the US FDA. Once a medicine is on sale, you must watch for side effects and report them.

Services that help

Industry

Medical devices and MedTech

The rules you face

In India, medical devices follow the Medical Devices Rules, 2017, under the Drugs and Cosmetics Act. Devices are sorted into four risk classes, from A (lowest risk) to D (highest risk). The class decides how you get a licence.

In the US, the US FDA clears most devices through routes such as 510(k) or De Novo. In Europe, devices must meet EU MDR, the EU Medical Device Regulation.

Once a device is in use, problems with it must be reported. In India, this is part of materiovigilance: watching for problems with medical devices.

Services that help

Industry

Food and FMCG

The rules you face

FMCG means fast-moving consumer goods: everyday products such as food, drinks and personal care. In India, food is controlled by FSSAI under the Food Safety and Standards Act, 2006.

Cosmetics follow different rules. They come under CDSCO and the Cosmetics Rules, 2020.

Labels and claims are checked closely. A claim such as "kills germs" or "lasts 12 months" needs test results to back it up.

Services that help

Industry

Nutraceuticals

The rules you face

Nutraceuticals are health supplements and foods with an added health benefit. In India, they are controlled by FSSAI, not CDSCO.

They follow FSSAI's regulations for health supplements and nutraceuticals, first made in 2016.

A health claim must be backed by evidence. If your product treats or prevents a disease, it may count as a medicine instead.

Services that help

Industry

Biotechnology

The rules you face

Biotechnology uses living cells to make or test products. A biotech product that is a medicine goes through CDSCO, like any other medicine.

Work with genetically modified organisms (living things whose genes have been changed) has extra rules. In India, committees called RCGM and GEAC review it.

Early on, the hard part is often knowing which rules apply at all. Deciding this early saves time later.

Services that help

Industry

Biologics and vaccines

The rules you face

Biologics are medicines made from living cells, such as antibodies and vaccines. In India, they are approved by CDSCO under the New Drugs and Clinical Trials Rules, 2019.

Similar biologics (close copies of an approved biologic) have their own Indian guidelines. In the US, a new biologic needs a BLA (Biologics License Application) with the US FDA.

Vaccine batches are tested before release. Side effects after vaccination must be watched for and reported.

Services that help

Industry

AI in healthcare

The rules you face

If software is meant to diagnose, treat or monitor patients, it can count as a medical device. This is called software as a medical device. In India, such software can come under the Medical Devices Rules, 2017.

The US FDA and EU MDR also regulate medical software. They want proof that it works on data it has not seen before.

Health data is personal data. In India, the Digital Personal Data Protection Act, 2023 (DPDP Act) sets the rules for using it.

Services that help

Industry

Universities and research

The rules you face

Research with people needs approval from an ethics committee first. In India, ICMR (the Indian Council of Medical Research) sets the national ethical guidelines for this research.

Clinical trials in India must be registered with CTRI, the Clinical Trials Registry of India, before the first person joins.

If you want to turn your research into a product, the product rules apply too. Planning for them early saves time.

Services that help

Industry

Hospitals

The rules you face

Hospitals that host clinical trials must follow GCP (Good Clinical Practice): the international rules for running trials safely and fairly.

Ethics committees that review clinical trials in India must be registered with CDSCO.

Doctors and hospitals can report side effects of medicines to PvPI, India's drug safety programme. Problems with medical devices go to MvPI, India's device safety programme.

Services that help

Industry

Community healthcare

The rules you face

Community healthcare brings care to people where they live, often through health workers and local groups. We support community programmes such as cancer screening, and studies for rare diseases (orphan drugs).

Research in communities needs ethics committee approval. People must agree to take part after it is explained in a language they understand.

Personal and health data must be protected under the DPDP Act, 2023.

Services that help

Not listed?

Not sure your product fits?

Tell us what your product is. We will tell you which rules apply and how we can help.

Ask us →

Start a conversation

Tell us about your product.

We will tell you which rules apply, and which of our services can help. Then we plan the work around those rules.